TabletsTablets
Schedule H (Prescription Required)Antiparkinson & Cognitive CareCode: 1919

Bromocriptine Mesylate Tablets 1.25 mg

Generic Formulation:Bromocriptine Mesylate Tablets IP 1.25 mg
Pack Size:10's
Common Commercial Brand Equivalents:Market reference only
Jan Aushadhi MRP
₹32.81
Brand Estimate*
₹101.92
Estimated Savings:₹69.11 (68% saved)
Find a Kendra Near You
*Statutory price across 21,118 listed Kendras
Clinical InformationReport Error

Clinical Overview

Bromocriptine Mesylate is a semisynthetic ergot alkaloid derivative that acts as a potent dopamine D2 receptor agonist and partial D1 receptor antagonist. In the tuberoinfundibular pathway, it inhibits pituitary prolactin secretion; in the striatum, it stimulates dopamine receptors to improve motor deficits. Indicated for hyperprolactinemia-associated disorders (amenorrhea, galactorrhea, prolactin-secreting adenomas), acromegaly, and Parkinson's disease.

Active Pharmaceutical Ingredients

AI-assistedClinical summary synthesized from pharmacopoeial references (CDSCO, WHO EML, IP/BP/USP). Not clinician-reviewed. Drug code 1919.Report inaccuracy

Usage Guidelines

Take orally strictly with food or a meal to minimize severe nausea and orthostatic dizziness. Titrate slowly starting with a low bedtime dose. Follow doctor's schedule.

General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.

Possible Side Effects

Common: Nausea, vomiting, dizziness, drowsiness, headache, nasal congestion, abdominal cramps. Rare/Severe: Severe orthostatic hypotension, retroperitoneal and pleuropulmonary fibrosis, cardiac valvulopathy with long-term use, and psychosis.

*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.

Precautions & Warnings

Contraindicated in uncontrolled hypertension, severe ischemic heart disease, and toxemia of pregnancy. Long-term high-dose therapy requires periodic echocardiographic and pulmonary screening for fibrotic complications.

Schedule H (Prescription Required)

This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.

Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered medical practitioner or qualified pharmacist before initiating, modifying, or substituting any medication regimen.